Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.38 USD | +0.34% | +0.21% | +511.36% |
05-09 | Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-02 | North American Morning Briefing : Stocks Seen -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+511.36% | 69.71M | |
+32.92% | 50.85B | |
+1.07% | 42.82B | |
+49.05% | 42.03B | |
-4.22% | 29.55B | |
+11.07% | 26.11B | |
-21.47% | 19.13B | |
+8.41% | 13.05B | |
+27.29% | 12.16B | |
+23.47% | 12.08B |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- JPMorgan Adjusts Price Target on Landos Biopharma to $7 From $15, Maintains Neutral Rating